All Articles

A top industry award reveals it's not just Laserfiche's new agentic AI that drives a 99% renewal rate, but a deep-seated culture of customer partnership.

A landmark agreement gives Premier's 4,350-hospital network streamlined access to Bluesight’s AI-powered suite for drug diversion and supply chain management.

A groundbreaking study ranks NFL owners by their AI-rendered reputations, showing single scandals can erase decades of success, signaling a new era for PR.

Daniel Wolfe's appointment as Editor-in-Chief signals a major pivot for Digital Insurance, doubling down on AI as a definitive growth signal for the industry.

Millions suffer from chronic sciatica with few good options. A small biotech is betting on a novel, non-opioid drug to fix the problem, not just mask it.

A major financial outlook warns that geopolitical fragmentation, stubborn inflation, and a new AI arms race are creating a new reality for investors.

A seismic shift is underway in the beauty industry. The era of sprawling global supply chains is giving way to a new, agile model of local-first production.

Crum & Forster's recent marketing awards are more than trophies. They are a blueprint for how legacy firms can master innovation, from AI adoption to CEO-led narrative.

Beacon Biosignals is merging AI-driven brain monitoring with home sleep testing, creating a powerful new platform that could redefine neurological diagnostics.

Polish biotech firm Urteste S.A. enrolls its first patient in a pivotal trial for a non-invasive pancreatic cancer test, a milestone in the global race for early diagnosis.

Futuri launches TopLine Enterprise, promising massive ROI by automating sales admin. We analyze if its data-centric approach can cut through a crowded AI market.

MAIA Biotechnology isn't just opening a new trial site; it's accelerating its assault on a $70B market with a drug showing remarkable early results.

A new partnership brings enterprise-grade governance to AI-generated code, aiming to solve the growing security blind spot in automated software development.

SEALSQ's CEO leads a crucial quantum semiconductor talk in Munich, highlighting the race to scale quantum tech and the urgent need for post-quantum security.

Swedish freight-tech leader Einride's explosive Nasdaq debut validates a ten-year mission to build the resilient, autonomous future of supply chains.

A landmark bill aims to end U.S. reliance on foreign magnets by incentivizing domestic production, including innovative rare-earth-free alternatives.

A new memorial on the National Mall uses reclaimed combat steel and data from 20,000 veterans to create a living tribute for a post-9/11 generation.

A new Florida venture embeds sleep apnea treatment into cardiology care, a model that could reshape patient outcomes and Vivos Therapeutics' market strategy.

Komodor's new AI platform moves beyond reactive fixes, proactively preventing the structural inefficiencies that strand up to 30% of Kubernetes capacity.

A market set to triple, driven by gene-level therapies, promises a revolution for children with rare epilepsies. But can our systems deliver this hope?